Возможности оценки плотности печени по данным бесконтрастной компьютерной томографии

С учетом широкой распространенности диффузных заболеваний печени, в частности, неалкогольной жировой болезни печени возникает необходимость в проведении максимально объективной оценки состояния этого органа. Одним из важнейших критериев такой оценки является определение показателей плотности печеночной ткани. Сегодня, благодаря внедрению таких программ, как скрининг рака легкого с помощью низкодозной компьютерной томографии, имеется возможность выполнения массовых исследований в этом направлении. В данном обзоре литературы рассматриваются достоинства и недостатки применения компьютерной томографии для выявления диффузных поражений печени.

1. Kim Y., Ejaz A., Tayal A., Spolverato G., Bridges J.F.P., Anders R.A., Pawlik T.M. Temporal trends in populationbased death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years. Cancer. 2014; 120 (19): 3058–3065. DOI:10.1002/cncr.28843

2. Marchesini G., Day Ch.P., Dufour J.F., Canbay A., Nobili V., Ratziu V. et al. EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Journal of Hepatology. 2016; 64(6): 1388–1402. DOI:10.1016/j.jhep.2015.11.004

3. Араблинский А.В., Чеченов M.Х. К вопросу о неинвазивной диагностике жирового гепатоза при неалкогольном стеатогепатите. Медицинская визуализация. 2008; (1): 46-51.

4. Hamabe A., Uto H., Imamura Y., Kusano K., Mawatari S., Kumagai K. et al. Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period. Journal of Gastroenterology. 2011; 46(6): 769–778. DOI:10.1007/s00535-011-0376-z

5. Armstrong M. J., Adams L. A., Canbay A., Syn W.K. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology. 2014; 59(3): 1174–1197. DOI: 10.1002/hep.26717

6. Mikolasevic I., Milic S., Turk Wensveen T., Grgic I., Jakopcic I., Stimac D. et al. Nonalcoholic fatty liver disease – A multisystem disease? World Journal of Gastroenterology. 2016; 22(43): 9488–9505. DOI 10.3748/wjg.v22.i43.9488

7. Ma X., Holalkere N.S., Kambadakone R. A., MinoKenudson, M., Hahn P. F., Sahani D. V. Imaging-based Quantification of Hepatic Fat: Methods and Clinical Applications. RadioGraphics. 2009; 29(5): 1253–1277. DOI: 10.1148/rg.295085186

8. Варначева Л. Н., Шабунина Е. И., Лаврова А. Е., Коркоташвили Л. В., Сазанова, Н. Е., Абрамов, С. А., Дмитриева, Г. В., Галова, Е. А., Борисова, Е. Ю.. Метаболические заболевания печени у детей, диагностика и лечение. Медицинский альманах. 2010; 4 (13): 211-214.

9. Kodama Y., Ng Ch. S., Wu T. T., Ayers G. D., Curley S. A., Abdalla E. K. et al. Comparison of CT methods for determining the fat content of the liver. American Journal of Roentgenology. 2007; 188(5): 1307–1312. DOI: 10.2214/AJR.06.0992

10. Pickhardt P.J., Park S.H., Hahn L., Lee S.-G., Bae K.T., Yu E.S. Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: Implications for the investigation of the natural history of incidental steatosis. European Radiology. 2012; 22 (5): 1075–1082. DOI: 10.1007/s00330-011-2349-2

11. Banerjee R., Pavlides M., Tunnicliffe E. M., Piechnik S. K., Sarania N., Philips R. et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. Journal of Hepatology. 2014; 60(1): 69–77. DOI: 10.1016/j.jhep.2013.09.002

12. Павлов Ч.С., Ивашкин В.Т. Биопсия печени: методология и практика сегодня. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2006; 16 (4): 65–78.

13. Bulut M.D., OЁzdemir H., Bora A., Yavuz A., Arslan H., Batur A. et al. Comparison of computed tomography densitometry and shear wave elastography velocity measurements for evaluation of the liver volume in the nonalcoholic fatty liver disease. International journal of clinical and experimental medicine. 2016; 9(6): 10159–10169.

14. Graffy P. M., Pickhardt P. J. Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD. The British Journal of Radiology. 2016; 89(1062). DOI: 10.1259/bjr.20151024

15. Boyce C.J., Pickhardt P.J., Kim D.H., Taylor A.J., Winter T.C., Bruce R.J. et al. Hepatic Steatosis (Fatty Liver Disease) in Asymptomatic Adults Identified by Unenhanced Low-Dose CT. American Journal of Roentgenology. 2010; 194 (3): 623–628. DOI: 10.2214/ajr.09.2590

16. Ricci C., Longo R., Gioulis E., Bosco M., Pollesello P., Masutti F. et al. Noninvasive in vivo quantitative assessment of fat content in human liver. Journal of Hepatology. 1997; 27(1): 108–113. DOI: 10.1016/s0168-8278(97)80288-7

17. Johnston R. J., Stamm E. R., Lewin J. M., Hendrick R. E., Archer P. G. Diagnosis of fatty infiltration of the liver on contrast enhanced CT: limitations of liver-minus-spleen attenuation difference measurements. Abdominal Imaging. 1998; 23(4): 409–415. DOI: 10.1007/s002619900370

18. Jacobs J. E., Birnbaum B. A., Shapiro M. A., Langlotz C. P., Slosman F., Rubesin S. E. et al. Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT. American Journal of Roentgenology. 1998; 171 (3): 659–664. DOI: 10.2214/ajr.171.3.9725292

19. Bydder G. M., Kreel L., Chapman R. W., Harry D., Sherlock S., Bassan L. Accuracy of computed tomography in diagnosis of fatty liver. BMJ. 1980; 281(6247): 1042–1042. DOI: 10.1136/bmj.281.6247.1042

20. Onuma Y., Tanabe K., Nakazawa G., Aoki J., Nakajima H., Ibukuro K. et al. Noncardiac Findings in Cardiac Imaging With Multidetector Computed Tomography. Journal of the American College of Cardiology. 2006; 48 (2): 402–406. DOI: 10.1016/j.jacc.2006.04.071

21. Vierikko T., Jarvenpaa R., Autti T., Oksa P., Huuskonen M., Kaleva S. et al. Chest CT screening of asbestos-exposed workers: lung lesions and incidental findings. European Respiratory Journal. 2006; 29 (1): 78–84. DOI: 10.1183/09031936.00073606

22. Ohtani O., Ohtani Y. Lymph Circulation in the Liver. The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology. 2008; 291 (6): 643–652. DOI: 10.1002/ar.20681

23. Lamba R., McGahan J.P., Corwin M. T., Li C.-S., Tran T., Seibert J.A. et al. CT Hounsfield Numbers of Soft Tissues on Unenhanced Abdominal CT Scans: Variability Between Two Different Manufacturers' MDCT Scanners. American Journal of Roentgenology. 2014; 203 (5): 1013–1020. DOI: 10.2214/ajr.12.10037

24. Speliotes E.K., Massaro J.M., Hoffmann U., Foster M.C., Sahani D.V, Hirschhorn J.N. et al. Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study. Journal of Gastroenterology and Hepatology. 2008; 23 (6): 894–899. DOI: 10.1111/j.1440-1746.2008.05420.x

25. Park S. H., Kim P. N., Kim K. W., Lee S. W., Yoon S. E., Park S.W. et al. Macrovesicular Hepatic Steatosis in Living Liver Donors: Use of CT for Quantitative and Qualitative Assessment. Radiology. 2006; 239 (1): 105–112. DOI: 10.1148/radiol.2391050361

26. Iwasaki M., Takada Y., Hayashi M., Minamiguchi S., Haga H., Maetani Y. et al. Noninvasive Evaluation of Graft Steatosis in Living Donor Liver Transplantation. Transplantation. 2004; 78 (10): 1501–1505. DOI: 10.1097/01.tp.0000140499.23683.0d

27. Zeb I., Li D., Nasir K., Katz R., Larijani V.N., Budoff M.J. Computed Tomography Scans in the Evaluation of Fatty Liver Disease in a Population Based Study. The Multi-Ethnic Study of Atherosclerosis. Academic Radiology. 2012; 19 (7): 811–818. DOI: 10.1016/j.acra.2012.02.022

28. Piekarski J., Goldberg H.I., Royal S.A., Axel L., Moss A.A. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology. 1980; 137 (3): 727–729. DOI: 10.1148/radiology.137.3.6934563

29. Yasaka K., Katsura M., Akahane M., Sato J., Matsuda I., Ohtomo K. Dose-reduced CT with model-based iterative reconstruction in evaluations of hepatic steatosis: How low can we go? European Journal of Radiology. 2014; 83 (7): 1063–1068. DOI: 10.1016/j.ejrad.2014.03.032

30. Siegelman E. S., Rosen M. A. Imaging of Hepatic Steatosis. Seminars in Liver Disease. 2001; 21 (01): 071–080. DOI: 10.1055/s-2001-12930

31. Gaba R.C., Knuttinen M.G., Brodsky T.R., Palestrant S., Omene B.O., Owens C.A. et al. Hepatic steatosis: correlation of bmi, CT fat measurements and liver density, and biopsy results. Diagnostic and Interventional Radiology. 2012; 18 (3): 282-287. DOI: 10.4261/1305-3825.dir.4958-11.2

32. Zhong L., Chen J.J., Chen J., Li L., Lin Z.Q., Wang W.J. et al. Nonalcoholic fatty liver disease: Quantitative assessment of liver fat content by computed tomography, magnetic resonance imaging and proton magnetic resonance spectroscopy. Journal of Digestive Diseases. 2009; 10 (4): 315–320. DOI: 10.1111/j.1751-2980.2009.00402.x

33. Gupta A.K., Bray G.A., Greenway F.L., Martin C.K., Johnson W.D., Smith S. R. Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes. Journal of Diabetes and Its Complications. 2010; 24 (5): 289–296. DOI:10.1016/j.jdiacomp.2009.05.004

34. Bae J.C., Lee W.Y., Yoon K.H., Park J.Y., Son H.S., Han K.A. et al. Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial. Diabetes Care. 2015; 38 (7): 1245–1252. DOI: 10.2337/dc14-2852

35. Devries M.C., Samjoo I.A., Hamadeh M.J., Tarnopolsky M.A. Effect of endurance exercise on hepatic lipid content, enzymes, and adiposity in men and women. Obesity and Metabolism. 2009; 6 (4): 49-50. DOI: 10.14341/2071-87134882

36. Faivre S., Zappa M., Vilgrain V., Boucher E., Douillard J.-Y., Lim H.Y. et al. Changes in Tumor Density in Patients with Advanced Hepatocellular Carcinoma Treated with Sunitinib. Clinical Cancer Research. 2011; 17 (13): 4504–4512. DOI: 10.1158/1078-0432.ccr-10-1708

37. Pickhardt P.J., Lubner M.G., Kim D.H., Tang J., Ruma J.A., Mun~oz del Rio A. et al. Abdominal CT With Model-Based Iterative Reconstruction (MBIR): Initial Results of a Prospective Trial Comparing Ultralow-Dose With StandardDose Imaging. American Journal of Roentgenology. 2012; 199 (6): 1266–1274. DOI: 10.2214/ajr.12.9382

38. Birnbaum B.A., Hindman N., Lee J., Babb J.S. Multi–Detector Row CT Attenuation Measurements: Assessment of Intraand Interscanner Variability with an Anthropomorphic Body CT Phantom. Radiology. 2007; 242 (1): 109–119. DOI: 10.1148/radiol.2421052066

39. Van de Wiel J.C.M., Wang Y., Xu D.M., van der ZaagLoonen H.J., van der Jagt E.J. et al. Neglectable benefit of searching for incidental findings in the Dutch–Belgian lung cancer screening trial (NELSON) using low-dose multidetector CT. European Radiology. 2007; 17 (6): 1474–1482. DOI: 10.1007/s00330-006-0532-7

40. MacRedmond R. Screening for lung cancer using low dose CT scanning. Thorax. 2004; 59 (3): 237–241. DOI: 10.1136/thx.2003.008821

41. Chen X., Li K., Yip R., Perumalswami P., Branch A.D., Lewis S. et al. Hepatic steatosis in participants in a program of lowdose CT screening for lung cancer. European Journal of Radiology. 2017; 94: 174–179. DOI: 10.1016/j.ejrad.2017.06.024

42. Hassan C. Computed Tomographic Colonography to Screen for Colorectal Cancer, Extracolonic Cancer, and Aortic Aneurysm Model Simulation With Cost-effectiveness Analysis. Archives of Internal Medicine. 2008; 168 (7): 696. DOI: 10.1001/archinte.168.7.696

43. Liao M., Zhao Y., Liu X., Zeng Y., Zou B., Wang X. et al. Automatic liver segmentation from abdominal CT volumes using graph cuts and border marching. Computer Methods and Programs in Biomedicine. 2017; 143: 1–12. DOI: 10.1016/j.cmpb.2017.02.015

44. Wu W., Zhou Z., Wu S., Zhang Y. Automatic Liver Segmentation on Volumetric CT Images Using SupervoxelBased Graph Cuts. Computational and Mathematical Methods in Medicine. 2016; 2016: 1–14. DOI: 10.1155/2016/9093721

45. Kullberg J., HedstroЁm A., Brandberg J., Strand R., Johansson L., BergstroЁm G. et al. Automated analysis of liver fat, muscle and adipose tissue distribution from CT suitable for large-scale studies. Scientific Reports. 2017; 7 (1): DOI: 10.1038/s41598-017-08925-8